Kerry Mahon

Kerry Mahon has extensive experience in the field of business development and innovation. Kerry currently holds the position of Senior Director of Innovation at Valo, a role they began in December 2020. Prior to this, Kerry worked at Verily Life Sciences from February 2016 to November 2020, where they were involved in corporate and business development.

Before their tenure at Verily, Kerry served as the Senior Manager of Business Development at Depomed, Inc. from June 2014 to February 2016. During this time, they played a key role in the $1 billion acquisition of Nucynta from Janssen. Their responsibilities included leading diligence activities and evaluating potential business opportunities.

Kerry also has experience working as the Director of Business Development at Applied Immunology from 2013 to 2014, and as the Manager of Scientific Development and Senior Scientist at Stemgent from 2008 to 2014. In these roles, they led various activities such as technology evaluation, product development, and managing collaborative agreements and licenses.

Additionally, Kerry has participated in the Startup Leadership Program as a Fellow, Class of 2013. Kerry has also worked as a Director of Business Development at both Cellaria Biosciences and Firefly Bioworks, and as a Program Manager and Scientist at Firefly Bioworks, where they advised on R&D and marketing strategies.

Kerry's academic background includes a postdoctoral research position at the Massachusetts Institute of Technology (MIT) from 2006 to 2008 and a visiting scientist role at MIT from 2008 to 2011, working in the laboratories of Prof. Dan Anderson and Prof. Robert Langer.

Kerry Mahon completed their education as follows:

From 1994 to 1998, they attended the College of the Holy Cross, where they earned a Bachelor of Arts (BA) degree in Chemistry.

Kerry then pursued further education at Boston College from 2001 to 2006, earning a Doctor of Philosophy (Ph.D.) degree in Chemistry, with a focus on Chemical Biology.

After completing their Ph.D., Kerry Mahon joined the Massachusetts Institute of Technology (MIT) for postdoctoral studies in Biomedical Engineering. Kerry attended MIT from 2006 to 2008.

In addition to their academic achievements, Kerry Mahon also obtained the Certified Licensing Professional (CLP) certification from Certified Licensing Professionals, Inc. in December 2015.